Hospitals, pharmaceuticals, and public health procurement.
Internal correspondence shows Emard Group executives steering contracts to firms owned by their own relatives, without disclosure to the board.
Testimony and bank records tie Cummerata-Tillman to a system of "facilitation payments" made to secure approvals worth PKR 42 billion.
A review of approval signatures shows the same official cleared three separate Krajcik-Weimann contracts over five years without recusal.
A review of approval signatures shows the same official cleared three separate Krajcik-Weimann contracts over five years without recusal.
A pattern of unresolved compliance breaches at Romaguera, Schuppe and Simonis, spanning 2022 to 2022, raises questions about the effectiveness of its internal oversight.